Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Sagara

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|August 5, 2017
Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013Yasuaki Sagara, Rachel A Freedman, Stephanie M Wong, et al.
Japanese Journal of Radiology|November 22, 2017
Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake valuesMichiro Sasaki, Mitsuhiro Tozaki, Kazunori Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2011
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy]Shugo Tamada, Yasuaki Sagara, Shinichi Baba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response]Yoshiaki Rai, Yoshiatsu Sagara, Yasuyo Ooi, et al.
Histopathology|March 5, 2011
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up studyTakako Yoshioka, Yoshihisa Umekita, Yasuyo Ohi, et al.
Annals of Surgical Oncology|July 24, 2015
Modern Trends in the Surgical Management of Paget's DiseaseStephanie M Wong, Rachel A Freedman, Emily Stamell, et al.
Breast Cancer Research and Treatment|July 21, 2023
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer RegistryYayoi Adachi, Sota Asaga, Hiraku Kumamaru, et al.
Histopathology|October 22, 2011
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancerYasuyo Ohi, Yoshihisa Umekita, Takako Yoshioka, et al.
Journal of Clinical Pathology|June 10, 2011
Practical considerations in the detection of HER2 status: the pathological perspectiveRin Yamaguchi, Shoshu Mitsuyama, Maki Tanaka, et al.
Breast Cancer (Tokyo, Japan)|October 12, 2012
Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapyTomohiko Aihara, Shiro Tanaka, Yasuaki Sagara, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|August 5, 2017
Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013Yasuaki Sagara, Rachel A Freedman, Stephanie M Wong, et al.
Japanese Journal of Radiology|November 22, 2017
Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake valuesMichiro Sasaki, Mitsuhiro Tozaki, Kazunori Kubota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2011
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy]Shugo Tamada, Yasuaki Sagara, Shinichi Baba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response]Yoshiaki Rai, Yoshiatsu Sagara, Yasuyo Ooi, et al.
Histopathology|March 5, 2011
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up studyTakako Yoshioka, Yoshihisa Umekita, Yasuyo Ohi, et al.
Annals of Surgical Oncology|July 24, 2015
Modern Trends in the Surgical Management of Paget's DiseaseStephanie M Wong, Rachel A Freedman, Emily Stamell, et al.
Breast Cancer Research and Treatment|July 21, 2023
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer RegistryYayoi Adachi, Sota Asaga, Hiraku Kumamaru, et al.
Histopathology|October 22, 2011
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancerYasuyo Ohi, Yoshihisa Umekita, Takako Yoshioka, et al.
Journal of Clinical Pathology|June 10, 2011
Practical considerations in the detection of HER2 status: the pathological perspectiveRin Yamaguchi, Shoshu Mitsuyama, Maki Tanaka, et al.
Breast Cancer (Tokyo, Japan)|October 12, 2012
Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapyTomohiko Aihara, Shiro Tanaka, Yasuaki Sagara, et al.
Pageof 14